Skip to content

Baxter International BAX Stock-Based Comp

Stock-Based Comp at other companies

Medtronic logo
MedtronicMDT
Medline, Inc.
 logo
Medline, Inc. MDLN
Solventum logo
SolventumSOLV
AptarGroup logo
AptarGroupATR
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
Nordson logo
NordsonNDSN

Other financials

Income statement

See full
Revenue$2.7B+2.9%
Gross profit$891.0M+3.5%
Operating income$66.0M+13.8%
Net income-$15.0M-112%
EPS (diluted)-$0.03-112%

Balance sheet

See full
Cash & equivalents$2.0B-12.1%
Total debt$224.0M-8.9%
Total equity$6.0B-14.7%
Total assets$19.8B-6.8%

Cash flow

See full
Operating cash flow$213.0M+210%
CapEx$128.3M+15.0%
Free cash flow$83.0M-42.1%

Valuation

See full
Market cap$10.27B-50.6%
Enterprise value$8.48B-55.6%
P/S0.9×-1.0×

Profitability

See full
Gross margin30.1%-5.9pp
Operating margin-2.7%
Net margin-9.7%+62.5pp
FCF margin3%-2.4pp

Returns & leverage

See full
Return on equity-16.7%-76.7pp
Debt / equity0.0×
Current ratio1.9×-0.2×

Where this comes from

Reported directly by Baxter International in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: Baxter International’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Baxter International's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Baxter International's stock-based comp?
Baxter International (BAX) reported stock-based comp of $10M in Q1 2026.
How has Baxter International's stock-based comp changed year-over-year?
Baxter International's stock-based comp decreased by 0.0% year-over-year, from $10M to $10M.
What is the long-term trend for Baxter International's stock-based comp?
Over 4 years (2021 to 2025), Baxter International's stock-based comp has grown at a -5.4% compound annual growth rate (CAGR), from $146M to $117M.